Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -15.009\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. CCC(=O)N1CCN(c2nc3ccc(Br)cc3s2)CC1
b. CN(C)C(=O)CSc1nc2ccccc2n1Cc1ccccc1
c. N#Cc1ccccc1OCC(=O)Nc1ccccc1C(=O)NC1CC1
Answer: a. CCC(=O)N1CCN(c2nc3ccc(Br)cc3s2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)N1CCN(c2nc3ccc(Br)cc3s2)CC1
CCC(=O)N1CCN(c2nc3ccc(Br)cc3s2)CC1
1-[4-(6-bromo-1,3-benzothiazol-2-yl)piperazin-1-yl]propan-1-one